Eight-year survival study of first-line tumour necrosis factor α inhibitors in rheumatoid arthritis: real-world data from a university centre registry.

Autor: Papadopoulos, Christos G, Gartzonikas, Ilias K, Pappa, Tatiani K, Markatseli, Theodora E, Migkos, Michael P, Voulgari, Paraskevi V, Drosos, Alexandros A

Publikováno v: Rheumatology Advances in Practice; 2019, Vol. 3 Issue 1, pN.PAG-N.PAG, 1p

Tuberculous pyomyositis in a rheumatoid arthritis patient treated with anakinra.

Autor: Migkos MP; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece., Somarakis GA; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece., Markatseli TE; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece., Matthaiou M; Pulmonary Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece., Kosta P; Department of Clinical Imaging and Radiology, Medical School, University of Ioannina, Ioannina, Greece., Voulgari PV; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece., Drosos AA; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2015 Sep-Oct; Vol. 33 (5), pp. 734-6. Date of Electronic Publication: 2015 May 01.